TABLE 1.
Substrate | MIC (μg/ml)
|
|||
---|---|---|---|---|
CF01Ent1 | E. coli DH5α (pCF01BA1-8) | E. coli DH5α (pCF01BA1-3) | E. coli DH5α | |
Amoxicillin | 32 | 256 | 1,024 | 2 |
Amoxicillin + CLAa | 32 | 256 | 1,024 | 2 |
Ticarcillin | 1 | 64 | 256 | 2 |
Ticarcillin + CLA | 0.5 | 64 | 256 | 2 |
Piperacillin | 2 | 8 | 32 | 2 |
Piperacillin + TZB | 2 | 8 | 32 | 2 |
Cephalothin | 64 | 256 | 512 | 4 |
Cefuroxime | 8 | 64 | 64 | 4 |
Cefoxitin | 32 | 128 | 128 | 4 |
Cefotaxime | 0.25 | 2 | 8 | 0.06 |
Cefpirome | 0.06 | 0.06 | 1 | 0.06 |
Cefepime | 0.06 | 0.06 | 1 | 0.06 |
Ceftazidime | 0.25 | 8 | 32 | 0.12 |
Aztreonam | 0.12 | 2 | 2 | 0.12 |
Imipenem | 0.5 | 0.25 | 0.25 | 0.12 |
Cla, clavulanate at a fixed concentration of 2 μg/ml; TZB, tazobactam at a fixed concentration of 4 μg/ml.